A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma

NCT06717126 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Uveal Melanoma
Ocular Melanoma

Interventions

DRUG: roginolisib
DRUG: Investigator choice of standard therapy

Sponsor

iOnctura